OPTACTO
DEAD

Serial Number

79092972

Owner

VELOXIS PHARMACEUTICALS A/S

Attorney

Bassam N. Ibrahim

Filing Date

Dec 23, 2010

Add to watchlist:

No watchlists yet
View on USPTO

OPTACTO Trademark

Serial Number: 79092972

OPTACTO is a trademark filed by VELOXIS PHARMACEUTICALS A/S on December 23, 2010. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

VELOXIS PHARMACEUTICALS A/S (27 trademarks)

KOGLE ALLE 4
DK-2970 HORSHOLM , DK

Entity Type: 99

Trademark Details

Filing Date

December 23, 2010

Registration Date

Not Registered

Goods & Services

Educational training services, namely, arranging and conducting of seminars, workshops, conferences, lectures and congresses in the field of medicine, health and pharmaceuticals

Treatment of materials, namely, milling, grinding, mixing, compressing and melting of pharmaceutical, medicinal, biotechnical and bacteriological substances, preparations, formulations, solutions for use in the pharmaceutical and medical industries

Pharmaceutical preparations, namely, tablets, granules, pills, sachets, powders, and capsules; all for use in the treatment of mental and physical disorders, traumas and emergencies, addictions, aging, allergy/immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical and gynecological field, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions in the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalized pain

Scientific research within the medical, pharmaceutical, biotechnical and bacteriological areas and providing consultation and information relating thereto; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; development of pharmaceutical and medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consulting and information thereto

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Sep 15, 2016 NREP
DEATH OF INTERNATIONAL REGISTRATION
Mar 30, 2012 DETH
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jan 26, 2012 ADCH
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 2, 2011 GNFN
FINAL REFUSAL E-MAILED
Nov 2, 2011 GNFR
FINAL REFUSAL WRITTEN
Nov 2, 2011 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 30, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 30, 2011 CRFA
ASSIGNED TO LIE
Sep 21, 2011 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 19, 2011 TROA
REFUSAL PROCESSED BY IB
Apr 9, 2011 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 18, 2011 RFCS
REFUSAL PROCESSED BY MPU
Mar 18, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 18, 2011 RFCR
NON-FINAL ACTION WRITTEN
Mar 17, 2011 CNRT
ASSIGNED TO EXAMINER
Mar 9, 2011 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 1, 2011 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 25, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 24, 2011 REPR